1 – 27 of 27
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Immune responses against oxidized LDL as possible targets for prevention of atherosclerosis in systemic lupus erythematosus
(
- Contribution to journal › Article
- 2019
-
Mark
High Levels of Soluble Lectinlike Oxidized Low-Density Lipoprotein Receptor-1 Are Associated With Carotid Plaque Inflammation and Increased Risk of Ischemic Stroke
(
- Contribution to journal › Article
- 2018
-
Mark
B cells treated with CTB-p210 acquire a regulatory phenotype in vitro and reduce atherosclerosis in apolipoprotein E deficient mice
(
- Contribution to journal › Article
- 2017
-
Mark
oxLDL antibody inhibits MCP-1 release in monocytes/macrophages by regulating Ca2+/K+ channel flow
(
- Contribution to journal › Article
-
Mark
High levels of (un)switched memory B cells are associated with better outcome in patients with advanced atherosclerotic disease
(
- Contribution to journal › Article
-
Mark
Vaccination against T-cell epitopes of native ApoB100 reduces vascular inflammation and disease in a humanized mouse model of atherosclerosis
(
- Contribution to journal › Article
- 2016
-
Mark
Association between renin and atherosclerotic burden in subjects with and without type 2 diabetes
(
- Contribution to journal › Article
-
Mark
Endarterectomy patients with elevated levels of circulating IL-16 have fewer cardiovascular events during follow-up
(
- Contribution to journal › Article
- 2012
-
Mark
High levels of IgM against methylglyoxal-modified apolipoprotein B100 is associated with less coronary artery calcification in patients with type 2 diabetes.
(
- Contribution to journal › Article
-
Mark
Regulatory T-Cell Response to Apolipoprotein B100-Derived Peptides Reduces the Development and Progression of Atherosclerosis in Mice
(
- Contribution to journal › Article
- 2011
-
Mark
Identification of a Danger-Associated Peptide From Apolipoprotein B100 (ApoBDS-1) That Triggers Innate Proatherogenic Responses
(
- Contribution to journal › Article
-
Mark
Immunization of apoE-/- mice with aldehyde-modified fibronectin inhibits the development of atherosclerosis.
(
- Contribution to journal › Article
- 2010
-
Mark
The pro-inflammatory effect of uraemia overrules the anti-atherogenic potential of immunization with oxidized LDL in apoE-/- mice
(
- Contribution to journal › Article
-
Mark
Intranasal Immunization With an Apolipoprotein B-100 Fusion Protein Induces Antigen-Specific Regulatory T Cells and Reduces Atherosclerosis
(
- Contribution to journal › Article
- 2007
-
Mark
Medial Expression of TNF-α and TNF Receptors Precedes the Development of Atherosclerotic Lesions in Apolipoprotein E/LDL Receptor Double Knockout Mice
(
- Contribution to journal › Article
-
Mark
Inhibition of injury-induced arterial remodelling and carotid atherosclerosis by recombinant human antibodies against aldehyde-modified apoB-100.
(
- Contribution to journal › Article
-
Mark
Association between IgM against an aldehyde-modified peptide in apolipoprotein B-100 and progression of carotid disease
(
- Contribution to journal › Article
-
Mark
Autoimmune responses against the apo B-100 LDL receptor-binding site protect against arterial accumulation of lipids in LDL receptor deficient mice.
(
- Contribution to journal › Article
- 2006
-
Mark
Identification of autoantibodies in human plasma recognizing an apoB-100 LDL receptor binding site peptide
(
- Contribution to journal › Article
-
Mark
Oxidized lipoprotein autoimmunity: an emerging drug target in cardiovascular disease
(
- Contribution to journal › Scientific review
- 2005
-
Mark
Very low density lipoprotein potentiates tumor necrosis factor-alpha expression in macrophages.
(
- Contribution to journal › Article
-
Mark
Humoral Immune Response Against Defined Oxidized Low-Density Lipoprotein Antigens Reflects Structure and Disease Activity of Carotid Plaques.
(
- Contribution to journal › Article
-
Mark
Immunization using an Apo B-100 related epitope reduces atherosclerosis and plaque inflammation in hypercholesterolemic apo E(-/-) mice
(
- Contribution to journal › Article
- 2004
-
Mark
Recombinant human antibodies against aldehyde-modified apolipoprotein B-100 peptide sequences inhibit atherosclerosis
(
- Contribution to journal › Article
- 2003
-
Mark
Identification of Immune Responses Against Aldehyde-Modified Peptide Sequences in ApoB Associated With Cardiovascular Disease.
(
- Contribution to journal › Article
-
Mark
Inhibition of Atherosclerosis in ApoE-Null Mice by Immunization with ApoB-100 Peptide Sequences.
(
- Contribution to journal › Article
- 2002
-
Mark
Inflammation and cholesterol
(
- Contribution to journal › Article